{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Outlook Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"OTLK"},"Address":{"label":"Address","value":"4260 U.S. ROUTE 1,SUITE 320, MONMOUTH JUNCTION, New Jersey, 08852, United States"},"Phone":{"label":"Phone","value":"+1 609 619-3990"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications."},"CompanyUrl":{"label":"Company Url","value":"https://www.outlooktherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Surendra Sharma","title":"Senior Vice President-Medical Affairs"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}